European equities traded in the US as American depositary receipts were slightly lower late Thursday morning, declining 0.12% to 1,510.10 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and financial services company Banco Bilbao Vizcaya Argentaria (BBVA), which rose 2.6% and 1.8%, respectively. They were followed by accommodations booking company trivago (TRVG) and financial services company Banco Santander (SAN), which were up 0.6% each.

The decliners from continental Europe were led by biotech firm Evaxion (EVAX) and semiconductor company Sequans Communications (SQNS), which fell 9.2% and 3.9%, respectively. They were followed by 3D printer company Materialise (MTLS) and internet browser company Opera (OPRA), which were down 2.6% and 2.4%, respectively.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech (TRIB), which soared 203%, followed by fellow biotech firm Autolus Therapeutics (AUTL), which advanced 4.1%. Biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) Amarin (AMRN) increased 2% and 0.7%, respectively.

And the decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and NuCana (NCNA), which dropped 11% and 6.4%, respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and pharmaceutical company Silence Therapeutics (SLN), which lost 3.8% and 2.4%, respectively.